Progress of Tumor Infiltrating Lymphocytes in Immunotherapy of Triple Negative Breast Cancer / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 475-480, 2021.
Article
Dans Chinois
| WPRIM
| ID: wpr-887882
ABSTRACT
Breast cancer has become the most common cancer for women in China.Lack of effective therapeutic targets,triple negative breast cancer(TNBC)has poorer prognosis compared with other subtypes of breast cancer.Tumor infiltrating lymphocytes(TILs)are a group of heterogeneous lymphocytes around the tumor,which are believed as immunoreactive products of host immune response to tumor antigens.At present,there have been reports on the predictive effect of TILs on the prognosis of breast cancer,and the available studies focus mainly on TNBC.This article briefly reviews the recent progress of tumor infiltrating lymphocytes in immunotherapy of TNBC.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pronostic
/
Marqueurs biologiques tumoraux
/
Chine
/
Lymphocytes TIL
/
Tumeurs du sein triple-négatives
/
Immunothérapie
Type d'étude:
Étude pronostique
Limites du sujet:
Femelle
/
Humains
Pays comme sujet:
Asie
langue:
Chinois
Texte intégral:
Acta Academiae Medicinae Sinicae
Année:
2021
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS